November is #NationalFamilyCaregiversMonth, a time to honor and celebrate the incredible #caregivers who provide invaluable support to the #hyperinsulinism community.
Hear more from caregivers here: bit.ly/46IK51G
#Rezolute #congenitalHI #tumorhyperinsulinism #raredisease #MedSky #EndoSky #PedSky
#Rezolute was proud to be a Diamond Sponsor of Congenital Hyperinsulinism International’s Sugar Soirée on Saturday, an annual fundraiser that supports families impacted by #congenitalHI and raises awareness.
Learn more about our Phase 3 trial in congenital HI here: bit.ly/47K5Oa3
#EndoSky #PedSky
To learn more about our sunRIZE Phase 3 preliminary demographic and baseline clinical characteristics, please check out our poster on our website: rezolutebio.com/wp-content/u... #SPES2025
#RZLT #CongenitalHI #raredisease #hyperinsulinism #ersodetug #PedSky #EndoSky #MedSky
Our team was proud to attend the Southern Ped Endo Society Annual Meeting at UAB in Birmingham this past weekend, presenting an encore poster presentation of the preliminary demographic and baseline clinical characteristics from our Phase 3 #sunRIZE trial. #RZLT #SPES2025 #RZLTInAction #CongenitalHI
Stay connected through The Rezolution—our new initiative for patients & caregivers featuring updates on therapies, advocacy, events & resources. Visit #RZLT For Patients page to learn more, meet our team & sign up for The Rezolution Report-our monthly newsletter bit.ly/46IK51G #congenitalHI #EndoSky
Proud to take part in this past weekend's 16th Annual Kongenitaler Hyperinsulinismus, e.V. meeting in Berlin, Germany. The Association continues to empower families facing #congenitalHI with education and support across every stage of life. #RareDisease #Hyperinsulinism #MedSky #EndoSky #PedSky
We applaud Congenital Hyperinsulinism International, the authors, and—most importantly—the patients and families—for their groundbreaking, innovative study on the real-world experience of diazoxide in congenital hyperinsulinism. #MedSky #EndoSky #PedSky #CongenitalHI #Hyperinsulinism
It was a privilege to connect with patients, caregivers, clinicians, and researchers who are united in advancing care for those affected by #cHI. We appreciate the ongoing collaboration and making a lasting impact for all those living with #hyperinsulinism!
#CongenitalHI #MedSky #EndoSky #RZLT
📈ICYMI we presented Preliminary Patient Demographics And Baseline Characteristics from Phase 3 Study #sunRIZE of Ersodetug for Hypoglycemia due to #CongenitalHI at #ENDO2025
📎 View the full poster here: bit.ly/416Pdt5
🙏Thank you to all who stopped by and engaged with us
#EndoSky #MedSky #Ph3 #RZLT
Proud to present "Preliminary Patient Demographics and Baseline Characteristics From a Phase 3 Study (sunRIZE) of Ersodetug for Hypoglycemia Due to Congenital Hyperinsulinism: Trial in Progress" today at #ENDO2025. View the full poster here: bit.ly/44x4GF6 #EndoSky #MedSky #CongenitalHi #RZLT
If you’re at #ENDO2025 join Rezolute's team today 4:30-6:30pm at the #HypoglycemiaHappyHour on top of Moscone Center North. Learn about our #InsulinReceptorModulatingAntibody ersodetug, and the growing body of evidence to treat all forms of #hyperinsulinism #PostBariatricHI #TumorHI #CongenitalHI
If attending the event, swing by to say hello on 7/14 at 12pm PT to learn more about this patient population and our progress in the space: bit.ly/3TqU1pf #ENDO2025 #ENDO #MedSky #PedSky #EndoSky #hypoglycemia #hyperinsulinism #congenitalHI #RZLT #Biotech
We're thrilled to present “Preliminary Patient Demographics And Baseline Characteristics From A Phase 3 Study (sunRIZE) Of Ersodetug For Hypoglycemia Due To Congenital Hyperinsulinism: Trial In Progress" at #ENDO2025 in San Francisco! #ENDO #MedSky #PedSky #CongenitalHI #RZLT #biotech
Dive into the latest issue to reacquaint yourself with our Phase 2b (RIZE) study on congenital hyperinsulinism and see the science behind the visuals! (4/4) www.sciencedirect.com/science/arti...
#MedSky #PedSky #CongenitalHI #Ersodetug #Hyperinsulinism #Hypoglycemia #RareDisease
🎨 Cover Art Reveal: Unpacking the Science 🧬
Checkout Med’s journal cover this month, which illustrates Ersodetug as an insulin receptor modulating antibody (1/4)
#Med #Ersodetug #MOA #RareDisease #Hyperinsulinism #CongenitalHI #Hypoglycemia #ScientificArt #VisualStorytelling #MedSky
💙 This dedicated German advocacy organization has been a tireless voice for those affected by congenital hyperinsulinism (HI) through their EDUCATION, VISIBILITY AND COHESION efforts. (3/3) #MedSky #PedSky #RareDisease #CongenitalHI #Hyperinsulinism #Hypoglycemia
With @chcharityuk.bsky.social, let’s continue to shine a light on this rare condition and the importance of timely diagnosis and better treatment options to reduce the burden of hypoglycemia and bring hope to those living with HI around the world! #MedSky #PedSky #RareDisease #CongenitalHI #CHCUK
🎗️ Today June 7th is Global Hyperinsulinism Awareness Day 🎗️Rezolute proudly stands with the incredible HI advocacy community who inspire our work every day.
@chcharityuk.bsky.social
#GlobalHIAwarenessDay #HyperinsulinismAwareness #AimHI #congenitalHI #CHCUK #RareDisease #RZLTCaresAboutRare (1/3)
✨ Help us shine a light on #CongenitalHI and the importance of timely diagnosis and better treatment options to protect young brains from preventable neurological harm. (3/3)
